Physician profile
Lauren Eberly
NPI 1487035754
$5,700.47
in general payments reported to CMS, 2019-2025
13 companies · $18.76 in 2025
The $18.76 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $52.45 · 2021: $62.46 · 2022: $181 · 2023: $5,130 · 2024: $156 · 2025: $18.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,010 · Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,010.00 |
| Food and Beverage | $294.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim International Gmbh | $2,610.00 | 2023 | Jardiance |
| Pfizer INC. | $2,425.68 | 2023 | |
| Novartis Pharmaceuticals Corporation | $181.18 | 2022-2024 | |
| Philips North America LLC | $94.34 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.15 | 2024 | Jardiance |
| Abiomed | $63.21 | 2019-2022 | |
| Abbott Laboratories | $55.77 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $55.76 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $53.73 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $46.15 | 2021 | |
| Amgen INC. | $18.76 | 2025 | Repatha |
| Lantheus Medical Imaging, INC. | $16.31 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Eberly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.